Millennium Pharmacon International (SDPC) — Capital Reinvestment Ratio
Millennium Pharmacon International (SDPC) has a Capital Reinvestment Ratio of 0.02x as of March 2025, meaning it reinvests 0% of its operating cash flow (Rp70.29 Billion) in capital expenditures (Rp1.09 Billion). See SDPC net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Millennium Pharmacon International Capital Reinvestment Ratio (2004–2022)
This chart tracks Millennium Pharmacon International's Capital Reinvestment Ratio across 8 annual periods. Check cash flow reinvestment rate of Millennium Pharmacon International to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Millennium Pharmacon International (2004–2022)
Year-by-year Capital Reinvestment Ratio for Millennium Pharmacon International from 2004 to 2022. For live market cap and broader valuation context, see Millennium Pharmacon International market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (IDR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.36x | Rp41.00 Billion | Rp14.68 Billion | ▲ +573.3% |
| 2020 | 0.05x | Rp71.69 Billion | Rp3.81 Billion | ▼ -96.0% |
| 2018 | 1.35x | Rp4.72 Billion | Rp6.35 Billion | ▼ -9.3% |
| 2017 | 1.48x | Rp4.46 Billion | Rp6.61 Billion | ▲ +160.6% |
| 2012 | 0.57x | Rp2.19 Billion | Rp1.25 Billion | ▼ -21.3% |
| 2007 | 0.72x | Rp4.57 Billion | Rp3.31 Billion | ▼ -26.7% |
| 2006 | 0.99x | Rp802.62 Million | Rp792.17 Million | ▲ +59.7% |
| 2004 | 0.62x | Rp2.72 Billion | Rp1.68 Billion | — |